Dr. Adam is a physician specializing in the evaluation and treatment of vein conditions, with a focus on providing personalized, patient-centered care. Through NY Metro Vein, he helps patients understand their vascular health and access appropriate treatment options for conditions such as varicose and spider veins.
His approach emphasizes accurate evaluation, minimally invasive treatment options when appropriate, and helping patients achieve both improved vein health and better quality of life. He believes patients should feel informed and comfortable throughout every stage of their care.
Company: Metropolitan Vein and Aesthetic Center in New York
We are thrilled to have you join us today, welcome to ValiantCEO Magazine’s exclusive interview! Let’s start off with a little introduction. Tell our readers a bit about yourself and your company.
Adam Goldman: Thank you for having me. I’m Dr. Adam, a physician focused on the diagnosis and treatment of vein conditions, and I’m proud to be part of NY Metro Vein.
Our practice is dedicated to providing patients with specialized care for venous conditions, including varicose and spider veins. We take a patient-centered approach, beginning with a thorough evaluation and then recommending treatment based on each patient’s individual condition, goals, and needs.
What I value most about our work is combining medical expertise with a comfortable, personalized patient experience. Many people live with vein problems for years without realizing that effective, minimally invasive treatment options may be available. Our goal is to educate patients, address their concerns, and help them make informed decisions about their vein health.
Ultimately, NY Metro Vein is about more than treating a condition—we want patients to feel confident that they are receiving thoughtful, specialized care from the first consultation through treatment and follow-up.
What was the pivotal pricing insight or experiment that most dramatically improved your company’s growth or profitability?
Adam Goldman: One of the most important pricing insights for our practice has been understanding that patients are looking for value, not simply the lowest price. In vein care, that value includes an accurate diagnosis, appropriate treatment, experienced medical care, convenience, and confidence in the overall patient experience.
That perspective has encouraged us to focus on clearly communicating what patients are receiving rather than competing primarily on price. We want patients to understand their treatment options, the reasons behind our recommendations, and the value of addressing their vein concerns appropriately.
Ultimately, sustainable growth in healthcare comes from building trust. When patients understand the quality and value of the care they receive, pricing becomes part of a much broader conversation about outcomes, expertise, and patient experience.
How do you determine the true value your product or service delivers to customers, and how does that shape your pricing strategy?
Adam Goldman: I determine the value we provide by looking at the complete patient experience, not simply the procedure itself. For patients dealing with vein conditions, value can mean getting an accurate evaluation, understanding their treatment options, receiving appropriate care, and being able to move forward with greater comfort and confidence.
That is why our approach starts with the individual patient. We consider their symptoms, medical needs, goals, and the most appropriate treatment options rather than taking a one-size-fits-all approach.
From a pricing perspective, transparency is essential. Patients should understand what they are paying for and why a particular treatment is being recommended. We focus on providing high-quality, specialized care and making sure the cost reflects the expertise, technology, personalized attention, and overall experience we provide. Ultimately, earning a patient’s trust is a much more important measure of value than simply being the lowest-priced option.
Can you share one pricing decision (such as packaging, tiering, or a bold price increase) that felt risky at the time but ultimately paid off significantly?
Adam Goldman: One decision that required us to think differently was putting greater emphasis on the value of specialized vein care rather than trying to compete primarily on price. In healthcare, lowering the price is not always the best answer because patients are ultimately looking for appropriate treatment, medical expertise, safety, and a positive experience.
It can feel risky to move away from a price-focused approach, but it has reinforced an important principle for our practice: patients need to understand what they are receiving and why a particular treatment is appropriate for them.
We have found that transparency and education make a significant difference. When patients understand the treatment process, the expertise involved, and the potential benefits, the conversation becomes less about finding the cheapest option and more about making the right healthcare decision. That has been valuable for both patient trust and the long-term growth of the practice.
How do you continuously test and refine pricing without alienating existing customers or damaging brand perception?
Adam Goldman: In healthcare, I believe pricing should be refined carefully and thoughtfully because patients are making decisions about their health, not simply purchasing a product. We pay attention to patient feedback, the demand for different services, operating costs, and the overall value and experience we provide.
When changes are necessary, transparency is extremely important. We want patients to understand what they are paying for and feel that the cost is fair in relation to the expertise, technology, personalized care, and treatment they receive.
I also believe consistency matters. We avoid making changes simply for the sake of increasing revenue. Any adjustment should support the quality of care we provide and the long-term relationship we have with our patients. Maintaining trust and delivering an excellent patient experience ultimately matter more than pursuing short-term pricing gains.
For other CEOs who still treat pricing as an afterthought, what’s the single most important mindset shift or first step you would recommend they take?
Adam Goldman: The most important mindset shift is to stop treating pricing as simply a financial decision and start treating it as part of the value you deliver.
In healthcare, that means understanding what patients truly value—expertise, appropriate treatment, safety, convenience, transparency, and the confidence that they are receiving the right care. Once you understand that, you can make pricing decisions from a position of value rather than simply trying to be the cheapest option.
My advice to other CEOs is to start by listening closely to their customers and understanding what outcomes they are willing to invest in. Then make sure the pricing, experience, and quality of service consistently support that value. Pricing should be reviewed and refined as the business evolves, but trust should always remain at the center of the decision.
